Kantarcioglu, B., Darki, A., Siddiqui, F., Hoppensteadt, D., Lewis, J., Krämer, R., . . . Fareed, J. (2022). The relevance of anti-pf4 antibody isotypes and endogenous glycosaminoglycans and their relationship with inflammatory biomarkers in pulmonary embolism patients. Clinical and applied thrombosis, hemostasis, 28, . https://doi.org/10.1177/10760296221091770
Chicago-Zitierstil (17. Ausg.)Kantarcioglu, Bulent, Amir Darki, Fakiha Siddiqui, Debra Hoppensteadt, Joseph Lewis, Roland Krämer, Cafer Adiguzel, und Jawed Fareed. "The Relevance of Anti-pf4 Antibody Isotypes and Endogenous Glycosaminoglycans and Their Relationship with Inflammatory Biomarkers in Pulmonary Embolism Patients." Clinical and Applied Thrombosis, Hemostasis 28 (2022). https://doi.org/10.1177/10760296221091770.
MLA-Zitierstil (9. Ausg.)Kantarcioglu, Bulent, et al. "The Relevance of Anti-pf4 Antibody Isotypes and Endogenous Glycosaminoglycans and Their Relationship with Inflammatory Biomarkers in Pulmonary Embolism Patients." Clinical and Applied Thrombosis, Hemostasis, vol. 28, 2022, https://doi.org/10.1177/10760296221091770.